Business Wire

CA-ZYNGA

Share
Zynga Announces First Quarter 2022 Financial Results

Zynga Inc. (NASDAQ: ZNGA) today released financial results for the first quarter ended March 31, 2022.

“We started off 2022 with a strong quarterly performance, achieving our highest ever Q1 advertising revenue and bookings led by our hyper-casual portfolio,” said Frank Gibeau, CEO of Zynga. “Through continued execution across all aspects of our multi-year growth strategy including live services, new game development and investments in our advertising platform, new markets and technologies, we are strengthening our position as a leading mobile-first, free-to-play live services company.”

First Quarter 2022 Financial Summary



$ in millions

Q1’22

Actuals

Q1’21

Actuals

Variance $

(Y/Y)

Variance %

(Y/Y)

 

 

 

 

 

Revenue

$

691

 

$

680

 

$

11

 

2

%

Net release of (increase in) deferred revenue (1)

$

(4

)

$

(39

)

$

36

 

(91

%)

Bookings

$

695

 

$

720

 

$

(25

)

(3

%)

 

 

 

 

 

Net income (loss)

$

(25

)

$

(23

)

$

(2

)

7

%

Adjusted EBITDA (2)

$

144

 

$

123

 

$

21

 

17

%

 

 

 

 

 

Note: Certain measures as presented differ due to the impact of rounding.

(1)

For clarity, a net release of deferred revenue results in revenue being higher than bookings and is a positive impact to Adjusted EBITDA as reported; a net increase in deferred revenue results in revenue being lower than bookings and is a negative impact to Adjusted EBITDA as reported.

(2)

Adjusted EBITDA includes the net release of (increase in) deferred revenue.

  • Revenue & Bookings: In Q1, we achieved revenue of $691 million, up 2% year-over-year, and quarterly bookings of $695 million, down 3% year-over-year. Online game or user pay revenue was $538 million, down 3% year-over-year, and user pay bookings were $528 million, down 11% year-over-year. Advertising & other revenue was a Q1 record of $154 million, up 24% year-over-year, and advertising & other bookings reached its highest Q1 performance of $167 million, up 35% year-over-year.
  • Audience Metrics: Average mobile daily active users (DAUs) were 40 million, up 3% year-over-year, and average mobile monthly active users (MAUs) were 209 million, up 27% year-over-year. Mobile average bookings per mobile DAU (ABPU) of $0.190 were down 6% year-over-year.
  • Costs & Expenses: Cost of revenue was $252 million or 36% of revenue, compared to 38% of revenue in the year-ago quarter. Non-GAAP cost of revenue was $185 million or 27% of bookings, down from 29% of bookings in the year-ago quarter. GAAP operating expenses were $424 million, representing 61% of revenue and an improvement from 62% in the year-ago quarter. Non-GAAP operating expenses of $364 million represented 52% of bookings, versus 49% in the year-ago quarter.
  • Profitability & Cash Flow: Net loss was $25 million, compared to a net loss of $23 million in the year-ago quarter, and Adjusted EBITDA was $144 million, up $21 million year-over-year. We had an operating cash outflow of $203 million versus a cash outflow of $164 million in the prior year quarter. In the quarter, we completed the final earn out payments related to the acquisitions of Small Giant Games and Rollic, totaling $265 million.

Due to the pending transaction with Take-Two Interactive Software, Inc. (“Take-Two”) announced on January 10, 2022, Zynga is not hosting a conference call or providing forward guidance in connection with the release of its quarterly results.

Additional information regarding the pending transaction with Take-Two is provided in a registration statement on Form S-4 filed by Take-Two with the U.S. Securities and Exchange Commission (the “SEC”) in connection with the transaction, which includes a joint proxy statement/prospectus of Zynga and Take-Two, and all other relevant documents filed with the SEC. The registration statement was declared effective on April 7, 2022 and the definitive joint proxy statement/prospectus was sent to Zynga and Take-Two stockholders.

About Zynga Inc.

Zynga is a global leader in interactive entertainment with a mission to connect the world through games. With massive global reach in more than 175 countries and regions, Zynga has a diverse portfolio of popular game franchises that have been downloaded more than four billion times on mobile including CSR Racing ™, Empires & Puzzles ™, FarmVille ™, Golf Rival ™, Hair Challenge ™, Harry Potter: Puzzles & Spells ™, High Heels! ™, Merge Dragons! ™, Merge Magic! ™, Toon Blast ™, Toy Blast ™, Words With Friends ™ and Zynga Poker ™. With Chartboost, a leading mobile advertising and monetization platform, Zynga is an industry-leading next-generation platform with the ability to optimize programmatic advertising and yields at scale. Founded in 2007, Zynga is headquartered in California with locations in North America, Europe and Asia. For more information, visit www.zynga.com or follow Zynga on Twitter, Instagram, Facebook or the Zynga blog.

Key Operating Metrics

We manage our business by tracking several operating metrics: “Mobile DAUs,” which measure daily active users of our mobile games, “Mobile MAUs,” which measure monthly active users of our mobile games, and “Mobile ABPU,” which measures our average daily mobile bookings per average Mobile DAU, each of which is recorded and estimated by our internal analytics systems. We determine these operating metrics by using internal company data based on tracking of user account activity. We also use information provided by third parties, including third party network logins provided by platform providers, to help us track whether a player logged in under two or more different user accounts is the same individual. Overall, we believe that the amounts are reasonable estimates of our user base for the applicable period of measurement and that the methodologies we employ and update from time-to-time are reasonably based on our efforts to identify trends in player behavior. However, factors relating to user activity and systems and our ability to identify and detect attempts to replicate legitimate player activity may impact these numbers.

Mobile DAUs. We define Mobile DAUs as the number of individuals who played one of our mobile games during a particular day. Average Mobile DAUs for a particular period is the average of the Mobile DAUs for each day during that period. Under this metric, an individual who plays two different mobile games on the same day is counted as two DAUs. We use information provided by third parties to help us identify individuals who play the same game to reduce this duplication. However, we do not have the third party network login data to link an individual who has played under multiple user accounts for our hyper-casual games (which includes the games acquired from Rollic in October 2020), mobile messenger games (prior to the third quarter of 2021), Puzzle Combat , Merge Magic! and games acquired from Gram Games in May 2018, Small Giant in January 2019, Peak in July 2020 and StarLark in October 2021, and accordingly, actual Mobile DAUs may be lower than reported due to the potential duplication of these individuals. We use Mobile DAUs as a measure of audience engagement.

Mobile MAUs. We define Mobile MAUs as the number of individuals who played one of our mobile games in the 30-day period ending with the measurement date. Average Mobile MAUs for a particular period is the average of the Mobile MAUs at each month-end during that period. Under this metric, an individual who plays two different mobile games in the same 30-day period is counted as two Mobile MAUs. We use information provided by third parties to help us identify individuals who play the same game to reduce this duplication. However, we do not have the third party network login data to link an individual who has played under multiple user accounts for our hyper-casual games (which includes the games acquired from Rollic in October 2020), mobile messenger games (prior to the third quarter of 2021), Puzzle Combat , Merge Magic! and games acquired from Gram Games in May 2018, Small Giant in January 2019, Peak in July 2020 and StarLark in October 2021, and accordingly, actual Mobile MAUs may be lower than reported due to the potential duplication of these individuals. We use Mobile MAUs as a measure of total game audience size.

Mobile ABPU. We define Mobile ABPU as our total mobile bookings in a given period, divided by the number of days in that period, divided by the average Mobile DAUs during the period. We believe that Mobile ABPU provides useful information to investors and others in understanding and evaluating our results in the same manner as management. We use Mobile ABPU as a measure of overall monetization across all of our players through the sale of virtual items and advertising.

Our business model around our social games is designed so that, as more players play our games, social interactions increase and the more valuable our games and our business become. All engaged players of our games help drive our bookings and, consequently, both online game revenue and advertising revenue. Virtual items are purchased by players who are socializing with, competing against or collaborating with other players, most of whom do not buy virtual items. Accordingly, we primarily focus on Mobile DAUs, Mobile MAUs and Mobile ABPU, which we believe collectively best reflect key audience metrics.

Non-GAAP Financial Measures

We have provided in this press release certain non-GAAP financial measures to supplement our consolidated financial statements prepared in accordance with U.S. GAAP (our “GAAP financial statements”). Management uses non-GAAP financial measures internally in analyzing our financial results to assess operational performance and liquidity. Our non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

The presentation of our non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, our GAAP financial statements. We believe that both management and investors benefit from referring to our non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. We believe our non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial measures we use in making operating decisions and because our investors and analysts use them to help assess the health of our business.

We have provided reconciliations of our non-GAAP financial measures used in this press release to the most directly comparable GAAP financial measures in the following tables. Because of the following limitations of our non-GAAP financial measures, you should consider the non-GAAP financial measures presented in this press release with our GAAP financial statements.

Key limitations of our non-GAAP financial measures include:

  • Bookings does not reflect that we defer and recognize online game revenue and revenue from certain advertising transactions over the estimated average playing period of payers for durable virtual items or as consumed for consumable virtual items; bookings also includes other adjustments, if applicable;
  • Adjusted EBITDA does not include the impact of stock-based compensation expense, acquisition-related transaction expenses, contingent consideration adjustments, legal settlements and related legal expense, and expenses incurred from vacated leases (which includes impairment charges recognized);
  • Adjusted EBITDA does not reflect provisions for or benefits from income taxes and does not include other income (expense) net, which includes foreign exchange and asset disposition gains and losses, interest expense and interest income;
  • Adjusted EBITDA excludes depreciation and amortization of tangible and intangible assets. Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized may have to be replaced in the future;
  • Free cash flow is derived from net cash provided by operating activities less cash spent on capital expenditures; and
  • Non-GAAP Cost of Revenue and Non-GAAP Operating Expenses do not include the impact of amortization of intangible assets from acquisitions, contingent consideration adjustments, acquisition-related transaction expenses, legal settlements and related legal expense, expenses incurred from vacated leases or stock-based compensation expense.

ZYNGA INC.

CONSOLIDATED BALANCE SHEETS

(In millions, unaudited)

 

 

 

March 31,

 

 

December 31,

 

 

 

2022

 

 

2021

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

826.0

 

 

$

984.0

 

Short-term investments

 

 

10.5

 

 

 

169.0

 

Accounts receivable, net of allowance of $0.9 at March 31, 2022 and December 31, 2021

 

 

233.4

 

 

 

242.5

 

Restricted cash

 

 

81.0

 

 

 

161.0

 

Prepaid expenses

 

 

68.4

 

 

 

56.7

 

Other current assets

 

 

47.4

 

 

 

35.4

 

Total current assets

 

 

1,266.7

 

 

 

1,648.6

 

Goodwill

 

 

3,586.8

 

 

 

3,601.1

 

Intangible assets, net

 

 

834.8

 

 

 

900.5

 

Property and equipment, net

 

 

36.6

 

 

 

30.3

 

Right-of-use assets

 

 

84.1

 

 

 

86.4

 

Restricted cash

 

 

0.2

 

 

 

40.2

 

Prepaid expenses

 

 

18.9

 

 

 

25.0

 

Other non-current assets

 

 

31.9

 

 

 

26.8

 

Total assets

 

$

5,860.0

 

 

$

6,358.9

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

48.4

 

 

$

95.6

 

Income tax payable

 

 

30.9

 

 

 

52.2

 

Deferred revenue

 

 

746.4

 

 

 

748.1

 

Operating lease liabilities

 

 

17.9

 

 

 

17.1

 

Other current liabilities

 

 

284.0

 

 

 

650.4

 

Total current liabilities

 

 

1,127.6

 

 

 

1,563.4

 

Convertible senior notes, net

 

 

1,542.1

 

 

 

1,343.8

 

Deferred revenue

 

 

0.3

 

 

 

0.3

 

Deferred tax liabilities, net

 

 

84.6

 

 

 

93.8

 

Non-current operating lease liabilities

 

 

131.6

 

 

 

133.4

 

Other non-current liabilities

 

 

67.7

 

 

 

112.3

 

Total liabilities

 

 

2,953.9

 

 

 

3,247.0

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock and additional paid-in capital

 

 

5,398.6

 

 

 

5,625.0

 

Accumulated other comprehensive income (loss)

 

 

(138.3

)

 

 

(107.1

)

Accumulated deficit

 

 

(2,354.2

)

 

 

(2,406.0

)

Total stockholders’ equity

 

 

2,906.1

 

 

 

3,111.9

 

Total liabilities and stockholders’ equity

$

5,860.0

 

$

6,358.9

ZYNGA INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except per share data, unaudited)

 

 

 

Three Months Ended

 

 

 

March 31, 2022

 

 

December 31, 2021

 

 

March 31, 2021

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Online game

 

$

537.7

 

 

$

534.0

 

 

$

557.0

 

Advertising and other

 

 

153.5

 

 

 

161.4

 

 

 

123.3

 

Total revenue

 

 

691.2

 

 

 

695.4

 

 

 

680.3

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

252.2

 

 

 

260.1

 

 

 

260.7

 

Research and development

 

 

112.4

 

 

 

151.9

 

 

 

140.7

 

Sales and marketing

 

 

251.1

 

 

 

245.6

 

 

 

248.7

 

General and administrative

 

 

60.5

 

 

 

39.1

 

 

 

35.7

 

Total costs and expenses

 

 

676.2

 

 

 

696.7

 

 

 

685.8

 

Income (loss) from operations

 

 

15.0

 

 

 

(1.3

)

 

 

(5.5

)

Interest income

 

 

0.9

 

 

 

1.4

 

 

 

1.7

 

Interest expense

 

 

(3.1

)

 

 

(15.0

)

 

 

(14.7

)

Other income (expense), net

 

 

(15.7

)

 

 

(10.2

)

 

 

8.9

 

Income (loss) before income taxes

 

 

(2.9

)

 

 

(25.1

)

 

 

(9.6

)

Provision for (benefit from) income taxes

 

 

21.6

 

 

 

42.1

 

 

 

13.4

 

Net income (loss)

 

$

(24.5

)

 

$

(67.2

)

 

$

(23.0

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.02

)

 

$

(0.06

)

 

$

(0.02

)

Diluted

 

$

(0.02

)

 

$

(0.06

)

 

$

(0.02

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares used to compute net income (loss) per share attributable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

1,133.2

 

 

 

1,124.9

 

 

 

1,084.4

 

Diluted

 

 

1,133.2

 

 

 

1,124.9

 

 

 

1,084.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense included in the above line items:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

0.7

 

 

$

0.8

 

 

$

0.6

 

Research and development

 

 

31.0

 

 

 

27.7

 

 

 

24.3

 

Sales and marketing

 

 

4.8

 

 

 

4.8

 

 

 

3.9

 

General and administrative

 

 

8.5

 

 

 

8.9

 

 

 

8.4

 

Total stock-based compensation expense

 

$

45.0

 

 

$

42.2

 

 

$

37.2

 

ZYNGA INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions, unaudited)

 

 

 

Three Months Ended

 

 

 

March 31, 2022

 

 

December 31, 2021

 

 

March 31, 2021

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(24.5

)

 

$

(67.2

)

 

$

(23.0

)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

69.2

 

 

 

68.2

 

 

 

56.5

 

Stock-based compensation expense

 

 

45.0

 

 

 

42.3

 

 

 

37.2

 

(Gain) loss from derivatives, sale of investments and other assets and foreign currency, net

 

 

26.6

 

 

 

18.3

 

 

 

(9.0

)

Noncash lease expense

 

 

3.9

 

 

 

4.0

 

 

 

4.2

 

Noncash interest expense

 

 

1.6

 

 

 

13.7

 

 

 

13.2

 

Change in deferred income taxes and other

 

 

(9.3

)

 

 

(6.9

)

 

 

(15.2

)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

8.2

 

 

 

(33.5

)

 

 

(59.5

)

Prepaid expenses and other assets

 

 

(19.2

)

 

 

(3.1

)

 

 

(2.0

)

Accounts payable

 

 

(46.3

)

 

 

45.0

 

 

 

(18.8

)

Deferred revenue

 

 

4.3

 

 

 

22.1

 

 

 

40.4

 

Income tax payable

 

 

(30.0

)

 

 

(20.4

)

 

 

5.9

 

Operating lease and other liabilities

 

 

(232.2

)

 

 

75.6

 

 

 

(193.6

)

Net cash provided by (used in) operating activities

 

 

(202.7

)

 

 

158.1

 

 

 

(163.7

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of investments

 

 

(2.2

)

 

 

(1.5

)

 

 

(537.2

)

Maturities of investments

 

 

84.8

 

 

 

83.5

 

 

 

83.9

 

Sales of investments

 

 

74.0

 

 

 

 

 

 

 

Acquisition of property and equipment

 

 

(10.3

)

 

 

(5.7

)

 

 

(1.7

)

Business combinations, net of cash acquired

 

 

(12.6

)

 

 

(286.1

)

 

 

(19.6

)

Release of restricted cash escrow from business combinations

 

 

(120.0

)

 

 

 

 

 

 

Asset acquisitions of intangible assets

 

 

(1.0

)

 

 

 

 

 

(0.9

)

Other investing activities, net

 

 

(20.4

)

 

 

(8.0

)

 

 

(0.3

)

Net cash provided by (used in) investing activities

 

 

(7.7

)

 

 

(217.8

)

 

 

(475.8

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Debt issuance costs paid

 

 

 

 

 

 

 

 

(0.9

)

Taxes paid related to net share settlement of stockholders' equity awards

 

 

(5.7

)

 

 

(2.5

)

 

 

(8.2

)

Proceeds from issuance of common stock

 

 

7.3

 

 

 

18.3

 

 

 

10.5

 

Acquisition-related contingent consideration payments

 

 

(56.6

)

 

 

 

 

 

(25.1

)

Net cash provided by (used in) financing activities

 

 

(55.0

)

 

 

15.8

 

 

 

(23.7

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

(12.6

)

 

 

(19.3

)

 

 

(1.7

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net change in cash, cash equivalents and restricted cash

 

 

(278.0

)

 

 

(63.2

)

 

 

(664.9

)

Cash, cash equivalents and restricted cash, beginning of period

 

 

1,185.2

 

 

 

1,248.4

 

 

 

1,500.4

 

Cash, cash equivalents and restricted cash, end of period

 

$

907.2

 

 

$

1,185.2

 

 

$

835.5

ZYNGA INC.

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(In millions, unaudited)

 

 

 

Three Months Ended

 

 

 

March 31, 2022

 

 

December 31, 2021

 

 

March 31, 2021

 

Reconciliation of Revenue to Bookings: Total

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

691.2

 

 

$

695.4

 

 

$

680.3

 

Change in deferred revenue

 

 

3.7

 

 

 

21.2

 

 

 

39.2

 

Other bookings adjustments

 

 

 

 

 

10.0

 

 

 

 

Bookings

 

$

694.9

 

 

$

726.6

 

 

$

719.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Revenue to Bookings: Mobile

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

672.2

 

 

$

673.9

 

 

$

660.7

 

Change in deferred revenue

 

 

3.8

 

 

 

21.1

 

 

 

38.9

 

Bookings

 

$

676.0

 

 

$

695.0

 

 

$

699.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Revenue to Bookings: Online Game

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

537.7

 

 

$

534.0

 

 

$

557.0

 

Change in deferred revenue

 

 

(9.4

)

 

 

21.2

 

 

 

39.3

 

Bookings

 

$

528.3

 

 

$

555.2

 

 

$

596.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Revenue to Bookings: Advertising & Other

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

153.5

 

 

$

161.4

 

 

$

123.3

 

Change in deferred revenue

 

 

13.0

 

 

 

0.1

 

 

 

(0.1

)

Other bookings adjustments

 

 

 

 

 

10.0

 

 

 

 

Bookings

 

$

166.5

 

 

$

171.5

 

 

$

123.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Net Income (Loss) to Adjusted EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(24.5

)

 

$

(67.2

)

 

$

(23.0

)

Provision for (benefit from) income taxes

 

 

21.6

 

 

 

42.1

 

 

 

13.4

 

Other expense (income), net

 

 

15.7

 

 

 

10.2

 

 

 

(8.9

)

Interest income

 

 

(0.9

)

 

 

(1.4

)

 

 

(1.7

)

Interest expense

 

 

3.1

 

 

 

15.0

 

 

 

14.7

 

Depreciation and amortization

 

 

68.7

 

 

 

67.6

 

 

 

56.5

 

Acquisition-related transaction expenses

 

 

12.5

 

 

 

4.6

 

 

 

1.5

 

Contingent consideration adjustments

 

 

(13.7

)

 

 

28.9

 

 

 

33.4

 

(Gain) loss on legal settlements and related legal expense

 

 

12.0

 

 

 

 

 

 

 

Expenses incurred from vacated lease(1)

 

 

4.9

 

 

 

4.6

 

 

 

 

Stock-based compensation expense

 

 

45.0

 

 

 

42.2

 

 

 

37.2

 

Adjusted EBITDA

 

$

144.4

 

 

$

146.6

 

 

$

123.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of GAAP Operating Expense to Non-GAAP Operating Expense

 

 

 

 

 

 

 

 

 

 

 

 

GAAP operating expense

 

$

424.0

 

 

$

436.6

 

 

$

425.1

 

Acquisition-related transaction expenses

 

 

(12.5

)

 

 

(4.6

)

 

 

(1.5

)

Contingent consideration adjustments

 

 

13.7

 

 

 

(28.9

)

 

 

(33.4

)

Gain (loss) on legal settlements and related legal expense

 

 

(12.0

)

 

 

 

 

 

 

Expenses incurred from vacated lease(1)

 

 

(4.9

)

 

 

(4.6

)

 

 

 

Stock-based compensation expense

 

 

(44.3

)

 

 

(41.4

)

 

 

(36.6

)

Non-GAAP operating expense

 

$

364.0

 

 

$

357.1

 

 

$

353.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Cash Provided by Operating Activities to Free Cash Flow

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) operating activities

 

$

(202.7

)

 

$

158.1

 

 

$

(163.7

)

Acquisition of property and equipment

 

 

(10.3

)

 

 

(5.7

)

 

 

(1.7

)

Free cash flow

 

$

(213.0

)

 

$

152.4

 

 

$

(165.4

)

(1)

Amount includes impairment charges (if applicable), rent and other expenses (including depreciation) associated with our impaired office buildings.

ZYNGA INC.

RECONCILIATION OF GAAP TO NON-GAAP COSTS AND EXPENSES

(In millions, unaudited)

 

 

 

 

 

 

Three Months Ended March 31, 2022

 

 

 

GAAP
measure

 

 

Amortization
of intangible
assets from
acquisitions

 

 

Contingent
consideration
adjustments

 

 

Acquisition
related
expenses

 

 

Gain (loss)
on legal
settlements and
related
legal expense

 

 

Expenses
incurred
from
vacated
lease

 

 

Stock-based
compensation
expense

 

 

Non-GAAP
measure

 

Cost of revenue

 

252.2

 

 

 

(66.1

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.7

)

 

 

185.4

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

112.4

 

 

 

 

 

 

13.7

 

 

 

(1.3

)

 

 

 

 

 

 

 

 

(31.0

)

 

 

93.8

 

Sales and marketing

 

251.1

 

 

 

 

 

 

 

 

 

(0.1

)

 

 

 

 

 

 

 

 

(4.8

)

 

 

246.2

 

General and administrative

 

60.5

 

 

 

 

 

 

 

 

 

(11.1

)

 

 

(12.0

)

 

 

(4.9

)

 

 

(8.5

)

 

 

24.0

 

Total operating expenses

 

 

424.0

 

 

 

 

 

 

13.7

 

 

 

(12.5

)

 

 

(12.0

)

 

 

(4.9

)

 

 

(44.3

)

 

 

364.0

 

Total costs and expenses

 

$

676.2

 

 

$

(66.1

)

 

$

13.7

 

 

$

(12.5

)

 

$

(12.0

)

 

$

(4.9

)

 

$

(45.0

)

 

$

549.4

 

 

 

Three Months Ended March 31, 2021

 

 

 

GAAP
measure

 

 

Amortization
of intangible
assets from
acquisitions

 

 

Contingent
consideration
adjustments

 

 

Acquisition
related
expenses

 

 

Gain (loss)
on legal
settlements and
related
legal expense

 

 

Expenses
incurred
from
vacated
lease

 

 

Stock-based
compensation
expense

 

 

Non-GAAP
measure

 

Cost of revenue

 

260.7

 

 

 

(52.8

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.6

)

 

 

207.3

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

140.7

 

 

 

 

 

 

(33.4

)

 

 

 

 

 

 

 

 

 

 

 

(24.3

)

 

 

83.0

 

Sales and marketing

 

 

248.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3.9

)

 

 

244.8

 

General and administrative

 

35.7

 

 

 

 

 

 

 

 

 

(1.5

)

 

 

 

 

 

 

 

 

(8.4

)

 

 

25.8

 

Total operating expenses

 

 

425.1

 

 

 

 

 

 

(33.4

)

 

 

(1.5

)

 

 

 

 

 

 

 

 

(36.6

)

 

 

353.6

 

Total costs and expenses

 

$

685.8

 

 

$

(52.8

)

 

$

(33.4

)

 

$

(1.5

)

 

$

 

 

$

 

 

$

(37.2

)

 

$

560.9

 

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release

Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr

IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release

Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye